Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats

BackgroundBesides hypertension, obesity and the metabolic syndrome have recently emerged as risk factors for atrial fibrillation. This study sought to delineate the development of an arrhythmogenic substrate for atrial fibrillation in hypertension with and without concomitant obesity and metabolic s...

Full description

Bibliographic Details
Main Authors: Mathias Hohl, Dennis H. Lau, Andreas Müller, Adrian D. Elliott, Benedikt Linz, Rajiv Mahajan, Jeroen M. L. Hendriks, Michael Böhm, Ulrich Schotten, Prashanthan Sanders, Dominik Linz
Format: Article
Language:English
Published: Wiley 2017-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006717
_version_ 1818398639788130304
author Mathias Hohl
Dennis H. Lau
Andreas Müller
Adrian D. Elliott
Benedikt Linz
Rajiv Mahajan
Jeroen M. L. Hendriks
Michael Böhm
Ulrich Schotten
Prashanthan Sanders
Dominik Linz
author_facet Mathias Hohl
Dennis H. Lau
Andreas Müller
Adrian D. Elliott
Benedikt Linz
Rajiv Mahajan
Jeroen M. L. Hendriks
Michael Böhm
Ulrich Schotten
Prashanthan Sanders
Dominik Linz
author_sort Mathias Hohl
collection DOAJ
description BackgroundBesides hypertension, obesity and the metabolic syndrome have recently emerged as risk factors for atrial fibrillation. This study sought to delineate the development of an arrhythmogenic substrate for atrial fibrillation in hypertension with and without concomitant obesity and metabolic syndrome. Methods and ResultsWe compared obese spontaneously hypertensive rats (SHR‐obese, n=7–10) with lean hypertensive controls (SHR‐lean, n=7–10) and normotensive rats (n=7–10). Left atrial emptying function (MRI) and electrophysiological parameters were characterized before the hearts were harvested for histological and biochemical analyses. At the age of 38 weeks, SHR‐obese, but not SHR‐lean, showed increased body weight and impaired glucose tolerance together with dyslipidemia compared with normotensive rats. Mean blood pressure was similarly increased in SHR‐lean and SHR‐obese when compared with normotensive rats (178±9 and 180±8 mm Hg [not significant] versus 118±5 mm Hg, P<0.01 for both), but left ventricular end‐diastolic pressure was more increased in SHR‐obese than in SHR‐lean. Impairment of left atrial emptying function, increase in total atrial activation time, and conduction heterogeneity, as well as prolongation of inducible atrial fibrillation durations, were more pronounced in SHR‐obese as compared with SHR‐lean. Histological and biochemical examinations revealed enhanced triglycerides and more pronounced fibrosis in the left atrium of SHR‐obese. Besides increased expression of profibrotic markers in SHR‐lean and SHR‐obese, the profibrotic extracellular matrix protein osteopontin was highly upregulated only in SHR‐obese. ConclusionsIn addition to hypertension alone, concomitant obesity and metabolic syndrome add to the atrial arrhythmogenic phenotype by impaired left atrial emptying function, local conduction abnormalities, interstitial atrial fibrosis formation, and increased propensity for atrial fibrillation.
first_indexed 2024-12-14T07:07:59Z
format Article
id doaj.art-4446522c540a4851a8ec1c4b1bc7e140
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-14T07:07:59Z
publishDate 2017-09-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-4446522c540a4851a8ec1c4b1bc7e1402022-12-21T23:12:04ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802017-09-016910.1161/JAHA.117.006717Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive RatsMathias Hohl0Dennis H. Lau1Andreas Müller2Adrian D. Elliott3Benedikt Linz4Rajiv Mahajan5Jeroen M. L. Hendriks6Michael Böhm7Ulrich Schotten8Prashanthan Sanders9Dominik Linz10Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, AustraliaKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, AustraliaKlinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, AustraliaCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, AustraliaKlinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyCardiovascular Research Institute Maastricht (CARIM), University Maastricht, Maastricht, The NetherlandsCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, Royal Adelaide Hospital, University of Adelaide, AustraliaKlinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyBackgroundBesides hypertension, obesity and the metabolic syndrome have recently emerged as risk factors for atrial fibrillation. This study sought to delineate the development of an arrhythmogenic substrate for atrial fibrillation in hypertension with and without concomitant obesity and metabolic syndrome. Methods and ResultsWe compared obese spontaneously hypertensive rats (SHR‐obese, n=7–10) with lean hypertensive controls (SHR‐lean, n=7–10) and normotensive rats (n=7–10). Left atrial emptying function (MRI) and electrophysiological parameters were characterized before the hearts were harvested for histological and biochemical analyses. At the age of 38 weeks, SHR‐obese, but not SHR‐lean, showed increased body weight and impaired glucose tolerance together with dyslipidemia compared with normotensive rats. Mean blood pressure was similarly increased in SHR‐lean and SHR‐obese when compared with normotensive rats (178±9 and 180±8 mm Hg [not significant] versus 118±5 mm Hg, P<0.01 for both), but left ventricular end‐diastolic pressure was more increased in SHR‐obese than in SHR‐lean. Impairment of left atrial emptying function, increase in total atrial activation time, and conduction heterogeneity, as well as prolongation of inducible atrial fibrillation durations, were more pronounced in SHR‐obese as compared with SHR‐lean. Histological and biochemical examinations revealed enhanced triglycerides and more pronounced fibrosis in the left atrium of SHR‐obese. Besides increased expression of profibrotic markers in SHR‐lean and SHR‐obese, the profibrotic extracellular matrix protein osteopontin was highly upregulated only in SHR‐obese. ConclusionsIn addition to hypertension alone, concomitant obesity and metabolic syndrome add to the atrial arrhythmogenic phenotype by impaired left atrial emptying function, local conduction abnormalities, interstitial atrial fibrosis formation, and increased propensity for atrial fibrillation.https://www.ahajournals.org/doi/10.1161/JAHA.117.006717atrial fibrillationhypertensionmetabolic syndromeobesity
spellingShingle Mathias Hohl
Dennis H. Lau
Andreas Müller
Adrian D. Elliott
Benedikt Linz
Rajiv Mahajan
Jeroen M. L. Hendriks
Michael Böhm
Ulrich Schotten
Prashanthan Sanders
Dominik Linz
Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atrial fibrillation
hypertension
metabolic syndrome
obesity
title Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
title_full Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
title_fullStr Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
title_full_unstemmed Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
title_short Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
title_sort concomitant obesity and metabolic syndrome add to the atrial arrhythmogenic phenotype in male hypertensive rats
topic atrial fibrillation
hypertension
metabolic syndrome
obesity
url https://www.ahajournals.org/doi/10.1161/JAHA.117.006717
work_keys_str_mv AT mathiashohl concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT dennishlau concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT andreasmuller concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT adriandelliott concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT benediktlinz concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT rajivmahajan concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT jeroenmlhendriks concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT michaelbohm concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT ulrichschotten concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT prashanthansanders concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats
AT dominiklinz concomitantobesityandmetabolicsyndromeaddtotheatrialarrhythmogenicphenotypeinmalehypertensiverats